Literature DB >> 10521954

Does aggressive surgical resection improve the outcome in advanced gallbladder carcinoma?

M Miyazaki1, H Ito, K Nakagawa, S Ambiru, H Shimizu, A Okuno, S Nozawa, Y Nukui, H Yoshitomi, S Furuya, K Kusashio, N Nakajima.   

Abstract

BACKGROUND/AIMS: Patients with advanced gallbladder carcinoma have usually been considered nonresectable, leading to a very poor outcome. This study was aimed to evaluate the results of our aggressive surgical approaches in certain cases of advanced gallbladder carcinoma.
METHODOLOGY: Ninety-one patients with advanced gallbladder carcinoma of stages pT3 and pT4 who underwent surgery at our institution were the subjects of this study. Fifty-eight of 91 patients had surgical excision; 44 by hepatic resection and 14 by hilar resection. Post-operative outcome was evaluated. Advanced gallbladder carcinomas were classified according to our previously reported classification: type I hepatic; type II biliary; type III hepatobiliary; type IV others.
RESULTS: Curative resection was obtained at a more increased rate in type I tumor patients than in types II and III (91% vs. 29%, p < 0.01). The surgical mortality rate was 17%. Survival rates of resected patients were significantly higher that those of nonresected patients: 45%, 31%, 22%, 17%, 13% at 1, 2, 3, 4, 5 years vs. 9%, 9%, 0% at 1, 2, 3 years (p < 0.01). Survival rates of type I tumor patients after curative resection were remarkably higher than those of type II and III tumor patients, (69%, 64%, 56%, 48%, 39% at 1, 2, 3, 4, 5 years vs. 17%, 17%, 0% at 1, 2, 3 years).
CONCLUSIONS: Aggressive surgical approaches might bring about improved prognosis in advanced gallbladder carcinoma, especially for patients with type I tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10521954

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Laparoscopic cholecystectomy for early gallbladder carcinoma: long-term outcome in comparison with conventional open cholecystectomy.

Authors:  K M Chan; T S Yeh; Y Y Jan; M F Chen
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

2.  Extrahepatic bile duct resection in gallbladder carcinoma: differentiated discussion about risk and oncological benefit.

Authors:  Ulrich Klaus Fetzner; Ionel Constantin Oana; Dirk L Stippel
Journal:  Saudi J Gastroenterol       Date:  2010 Oct-Dec       Impact factor: 2.485

3.  Appraisal of surgical treatment for pT2 gallbladder carcinomas.

Authors:  Shohachi Suzuki; Yoshihiro Yokoi; Kiyotaka Kurachi; Keisuke Inaba; Shigeyasu Ota; Masaki Azuma; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

4.  Endoscopic biliary imaging and clinicopathological features of cystic duct cancer.

Authors:  Takashi Obana; Naotaka Fujita; Yutaka Noda; Go Kobayashi; Kei Ito; Toshiki Sugawara; Jun Horaguchi; Osamu Takasawa; Takuro Endo; Kazunari Nakahara; Takashi Sawai; Miwa Uzuki; Mika Watanabe
Journal:  J Gastroenterol       Date:  2008-02-29       Impact factor: 7.527

5.  Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma.

Authors:  Seung Won Lee; Hong Joo Kim; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  J Gastroenterol       Date:  2009-12-25       Impact factor: 7.527

6.  Clinical and metabolic parameters for predicting disease progression of gallbladder adenocarcinoma.

Authors:  Yeon-Hee Han; Hwan-Jeong Jeong; Seok Tae Lim
Journal:  Nucl Med Commun       Date:  2022-01-01       Impact factor: 1.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.